key: cord-0740233-32zhozew
authors: Ravani, Swati A; Agrawal, Garima A; Leuva, Parth A; Modi, Palak H; Amin, Krisha D
title: Response to comments on: Rise of the phoenix: Mucormycosis in COVID-19 times
date: 2021-09-03
journal: Indian J Ophthalmol
DOI: 10.4103/ijo.ijo_1708_21
sha: 8463d4d79d08f1d9c550bdecdb505f13d38b761c
doc_id: 740233
cord_uid: 32zhozew

nan

Dear Editor, First, a huge thanks to the editors and reviewers of our article, "Rise of Phoenix: Mucormycosis in COVID-19 times" by Ravani Swati, Agrawal Garima, and colleagues. [1] We would like to thank you for the chance to correct and appreciate your patience regarding the corrections asked. [2] Starting with the values for HbA1c, it has been rightly pointed out that at few places the unit has been missed/misquoted, which we would like to clarify is % and not mmol/mol.

The usage of steroids was decided depending upon the patient condition and the physician's expertise and/or opinion, according to which the patients of our institute have received injection Dexamethasone in the dosages described, whereas the patients treated elsewhere have received either Injection Dexamethasone or Injection Methylprednisolone. The dosages of the same were not exactly known.

Regarding the fact about Type 1 and Type 2 diabetes mellitus, we agree with the commenters and would like to change it from roman numbering as and where required.

Regarding the P value, as per our knowledge, the decision about significance depends upon the researcher and thus it can be set by the researcher that such a test reveals a statistical analysis.

Rise of the phoenix: Mucormycosis in COVID-19 times

Comments on: Rise of the phoenix: Mucormycosis in COVID-19 times